HP and COVID-19: Hence, the detection of gut barrier defects using several indicators—including serum zonulin, the lactulose-to-mannitol excretion ratio, microbial molecules in serum without systemic infection (LPS and BG) [15,100], and/or NETosis determination—in patients with COVID-19 can indicate the disease severity.